Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation

[1]  L. Traeger,et al.  Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation , 2015, Cancer.

[2]  T. Pawlik,et al.  What are patients' expectations about the effects of chemotherapy for advanced cancer? , 2014, Journal of the American College of Surgeons.

[3]  L. Traeger,et al.  Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer , 2014, Cancer.

[4]  D. Roter,et al.  Preferences for and experiences of family involvement in cancer treatment decision‐making: patient–caregiver dyads study , 2013, Psycho-oncology.

[5]  J. Temel,et al.  Predicting life expectancy in patients with advanced incurable cancer: a review. , 2013, The journal of supportive oncology.

[6]  J. Temel,et al.  Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  H. Jim,et al.  Quality of life after allogeneic hematopoietic cell transplantation. , 2009, Blood.

[8]  P. Monahan,et al.  Adaptation of family caregivers during the acute phase of adult BMT , 2009, Bone Marrow Transplantation.

[9]  M. Adachi,et al.  Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non‐small cell lung cancer , 2009, Psycho-oncology.

[10]  D. Feeny,et al.  Health-related quality of life measures in routine clinical care: Can FACT-Fatigue help to assess the management of fatigue in cancer patients? , 2009, International Journal of Technology Assessment in Health Care.

[11]  P. Cleary,et al.  Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Gratwohl,et al.  EBMT activity survey 2004 and changes in disease indication over the past 15 years , 2006, Bone Marrow Transplantation.

[13]  R. Batiste,et al.  Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation , 2006, Bone Marrow Transplantation.

[14]  M. Sorror,et al.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. , 2005, Blood.

[15]  D. Cella,et al.  Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation. , 2004, Blood.

[16]  Phyllis N Butow,et al.  Cancer patient preferences for communication of prognosis in the metastatic setting. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  L. Siminoff,et al.  The role of the family in treatment decision making by patients with cancer. , 2003, Oncology nursing forum.

[18]  P. Butow,et al.  When the treatment goal is not cure: are cancer patients equipped to make informed decisions? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  K. Cornetta,et al.  Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation , 2001, Bone Marrow Transplantation.

[20]  D. Fairclough,et al.  Discrepancies between patient and physician estimates for the success of stem cell transplantation. , 2001, JAMA.

[21]  P. Bower,et al.  Patient-centredness: a conceptual framework and review of the empirical literature. , 2000, Social science & medicine.

[22]  H. Welch,et al.  Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews , 1998, BMJ.

[23]  E. Cook,et al.  Relationship between cancer patients' predictions of prognosis and their treatment preferences. , 1998, JAMA.

[24]  R. Hoover,et al.  Solid cancers after bone marrow transplantation. , 1997, The New England journal of medicine.

[25]  A. Tichelli,et al.  Health and Functional Status of Long-Term Survivors of Bone Marrow Transplantation , 1997, Annals of Internal Medicine.

[26]  A. Bonomi,et al.  Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale , 1997, Bone Marrow Transplantation.

[27]  F. Gaston‐Johansson,et al.  Burden and health outcomes of family caregivers of hospitalized bone marrow transplant patients. , 1996, Journal of advanced nursing.

[28]  J. E. Brazier,et al.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.

[29]  B. Kapp,et al.  A history and theory of informed consent , 1986 .

[30]  L. Díez Porres.  [Patients’ expectations about effects of chemotherapy for advanced cancer]. , 2013, Revista clínica española (Ed. impresa).

[31]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[32]  M. Brundage,et al.  Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  W. Weil.  Abandoning informed consent? , 1996, The Hastings Center report.

[34]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.